InflaRx (IFRX) Change in Receivables (2016 - 2018)
InflaRx's (IFRX) quarterly Change in Receivables came in at $81493.4 in Q4 2018, down 93.33% year-on-year from $1.2 million in Q4 2017, and up 110.1% quarter-over-quarter from -$807211.6 in Q3 2018.
InflaRx (IFRX) Change in Receivables (2016 - 2018) Analysis & Trends
InflaRx has disclosed Change in Receivables across 3 years of filings, most recently posting $81493.4 for Q4 2018.
- Change in Receivables for Q4 2018 came in at $81493.4, down 93.33% year-over-year; the trailing twelve-month figure through Dec 2018 was -$1.0 million (down 133.86% YoY), and the FY2021 annual result was -$8.1 million, down 337.86% from the prior year.
- Change in Receivables came in at $81493.4 for Q4 2018 at InflaRx, up from -$807211.6 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $1.2 million in Q4 2017 to a low of -$966503.9 in Q2 2017.
- The 3-year median for Change in Receivables is -$137125.0 (2016), against an average of -$181414.3.
- Across the five-year window, Change in Receivables surged 991.29% in 2017 and slumped 93.33% in 2018, its largest moves.
- InflaRx's Change in Receivables stood at -$137125.0 in 2016, then soared by 991.29% to $1.2 million in 2017, then tumbled by 93.33% to $81493.4 in 2018.
- The last three Change in Receivables figures came in at $81493.4 (Q4 2018), -$807211.6 (Q3 2018), and -$374741.5 (Q2 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -4.08 Mn |
| 10 | InflaRx | 764.68 Mn | 764.68 Mn | 10,877.40 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 81,493.42 |
| Dec 31, 2018 | 81,493.42 |
| Sep 30, 2018 | -807,211.65 |
| Sep 30, 2018 | -807,211.65 |
| Jun 30, 2018 | -374,741.55 |
| Jun 30, 2018 | -374,741.55 |
| Mar 31, 2018 | 52,826.91 |
| Mar 31, 2018 | 52,826.91 |
| Dec 31, 2017 | 1.22 Mn |
| Dec 31, 2017 | 1.22 Mn |
| Sep 30, 2017 | -781,417.07 |
| Sep 30, 2017 | -781,417.07 |
| Jun 30, 2017 | -966,503.85 |
| Jun 30, 2017 | -966,503.85 |
| Mar 31, 2017 | 77,774.70 |
| Mar 31, 2017 | 77,774.70 |
| Dec 31, 2016 | -137,124.98 |
| Dec 31, 2016 | -137,124.98 |